Xiong-Bin Hu

1.9k citations
34 papers · 1.5k indexed · 1 hit paper · h-index 19
Topics
Extracellular vesicles in disease (12 papers)RNA Interference and Gene Delivery (11 papers)MicroRNA in disease regulation (7 papers)
Partner nations
ChinaIrelandPoland

In The Last Decade

Xiong-Bin Hu

33 papers receiving 1.5k citations

Hit Papers

Artificial exosomes for translational nanomedicine2021202620222024202150100150200250

Peers

Xiong-Bin Hu
Comparison fields: 5 of 102
  • Molecular Biology 1.1k
  • Cancer Research 492
  • Biomedical Engineering 314
  • Immunology 172
  • Biomaterials 160
Replace Junyong Wu with:
Junyong Wu China
Jiemin Wang China
Shouying Du China
Zhen Huang China
Songwen Ju China
Alan Soo Beng Khoo Malaysia
Qin Shi Canada
Barbara Dapas Italy
Xiong-Bin Hu relative to Junyong Wu China Junyong Wu's profile →
Citations per field
00.5×1.5×1.8×
Junyong Wu · 1×
Citations per year

Countries citing papers authored by Xiong-Bin Hu

Since Specialization
Citations

This map shows the geographic impact of Xiong-Bin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiong-Bin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiong-Bin Hu more than expected).

Fields of papers citing papers by Xiong-Bin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiong-Bin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiong-Bin Hu. The network helps show where Xiong-Bin Hu may publish in the future.

Co-authorship network of co-authors of Xiong-Bin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiong-Bin Hu. A scholar is included among the top collaborators of Xiong-Bin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiong-Bin Hu. Xiong-Bin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 6
4 5
5 8
6 5
7 67
8 53
9 67
10 22
11 4
12 53
13 112
14 10
15 76
16 27
17 16
18 244
19 27
20 57

About Xiong-Bin Hu

Xiong-Bin Hu is a scholar working on Pharmaceutical Science, Cancer Research and Physiology, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (12 papers), RNA Interference and Gene Delivery (11 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (492 citations), Pharmaceutical Science (123 citations) and Molecular Biology (1.1k citations). Xiong-Bin Hu has collaborated with scholars based in China, Ireland and Poland. Frequent co-authors include Daxiong Xiang, Junyong Wu, Yongjiang Li, Jiemin Wang, Si Huang, Jiaxin Cai, Tiantian Tang, Wenjie Xu, Xiaohan Qiu and Jihua Liu. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia and International Journal of Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026